Erika Mansfield, MD
Family Medicine · Chesapeake, VANPI 1932164092
Payments from drug & device makers
Across 41 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$123
- AbbVie$117
- Lilly USA, LLC$98
- AstraZeneca$94
- Novo Nordisk$58
- Novartis$47
- plus $216 from 9 others
What the payments were for
- Food & beverage$754100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 6 | $123 |
| AbbVie | 5 | $117 |
| Lilly USA, LLC | 6 | $98 |
| AstraZeneca | 6 | $94 |
| Novo Nordisk | 3 | $58 |
| Novartis | 3 | $47 |
| GSK | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Sanofi Pasteur Inc. | 1 | $30 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Eisai Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Merck | 1 | $13 |
How this compares
$754 in reported general payments places this provider in the 65th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 42 | $433 |
| Atorvastatin Calcium | 33 | $281 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $277 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $181 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $161 |
| Cephalexin | 23 | $144 |
| Prednisone | 18 | $101 |
| Azithromycin | 19 | $74 |
| Fluconazole | 12 | $68 |
| Rosuvastatin Calcium | 17 | $65 |
| Levothyroxine Sodium | 11 | $51 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $41 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chesapeake
- Samir AbdelshaheedChesapeake$642K
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.